Skip to content

MEDESTIME: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

MEDESTIME

BE 0445.829.321
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€157,844
2024 · -€222,800+€64,955
Equity
-€678,663
2024 · -€520,818-€157,844
Cash
€1,451
2024 · €59+€1,392
Balance sheet total
€231,746
2024 · €256,364-€24,618

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€11,995

    down €11,995 (-22.1%), from €54,300 to €42,305

    of which Trade receivables: -€14,535

  • Tangible fixed assets -€8,871

    down €8,871 (-29.3%), from €30,318 to €21,447

  • Intangible fixed assets -€5,141

    down €5,141 (-20.0%), from €25,704 to €20,563

Equity and liabilities
  • Profit (loss) carried forward -€157,844

    down €157,844 (-23.6%), from -€667,608 to -€825,452

  • Other debts +€115,102

    up €115,102 (+17.6%), from €654,891 to €769,994

  • Trade debts +€27,574

    up €27,574 (+88.8%), from €31,041 to €58,615

  • Tax, wage and social debts -€9,450

    down €9,450 (-21.3%), from €44,334 to €34,884

    of which Remuneration and social security: -€10,665

Income statement
  • Gross operating margin +€50,901

    up €50,901 (+56.7%), from -€89,823 to -€38,922

  • Staff costs -€19,294

    down €19,294 (-15.8%), from €122,364 to €103,070

  • Depreciation +€5,062

    up €5,062 (+56.6%), from €8,949 to €14,011

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€222,800
Gross operating margin +€50,901
Staff costs +€19,294
Depreciation -€5,062
Other operating charges -€842
Financial income -€61
Financial charges +€757
Taxes -€32
Result 2025 -€157,844

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€1,392
Investment €0
Financing €0
Cash 2024 €59
Net result for the year -€157,844
Depreciation +€14,011
Receivables within one year +€11,995
Deferred charges and accrued income +€4
Trade debts +€27,574
Tax, wage and social debts -€9,450
Other debts +€115,102
Cash 2025 €1,451
Every line side by side 51 lines
Line Code 2024 2025 Change %
Total assets 20/58 €256,364 €231,746 -€24,618 -9.6%
Fixed assets 21/28 €57,038 €43,027 -€14,011 -24.6%
Intangible fixed assets 21 €25,704 €20,563 -€5,141 -20.0%
Tangible fixed assets 22/27 €30,318 €21,447 -€8,871 -29.3%
Land and buildings 22 €11,440 €7,622 -€3,818 -33.4%
Furniture and vehicles 24 €939 €276 -€663 -70.6%
Other tangible fixed assets 26 €17,939 €13,549 -€4,390 -24.5%
Financial fixed assets 28 €1,016 €1,016 = 0.0%
Current assets 29/58 €199,326 €188,719 -€10,607 -5.3%
Stocks and contracts in progress 3 €144,812 €144,812 = 0.0%
Stocks 30/36 €144,812 €144,812 = 0.0%
Amounts receivable within one year 40/41 €54,300 €42,305 -€11,995 -22.1%
Trade receivables 40 €51,663 €37,127 -€14,535 -28.1%
Other amounts receivable 41 €2,637 €5,178 +€2,540 +96.3%
Current investments 50/53 €124 €124 = 0.0%
Cash at bank and in hand 54/58 €59 €1,451 +€1,392 +2367.1%
Deferred charges and accrued income 490/1 €31 €27 -€4 -13.0%
Total equity and liabilities 10/49 €256,364 €231,746 -€24,618 -9.6%
Equity 10/15 -€520,818 -€678,663 -€157,844 -30.3%
Contributions 10/11 €123,947 €123,947 = 0.0%
Capital 10 €123,947 €123,947 = 0.0%
Issued capital 100 €123,947 €123,947 = 0.0%
Reserves 13 €22,843 €22,843 = 0.0%
Non-distributable reserves 130/1 €12,395 €12,395 = 0.0%
Legal reserve 130 €12,395 €12,395 = 0.0%
Distributable reserves 133 €10,448 €10,448 = 0.0%
Profit (loss) carried forward 14 -€667,608 -€825,452 -€157,844 -23.6%
Investment grants 15 €0 €0 =
Amounts payable 17/49 €777,182 €910,409 +€133,226 +17.1%
Amounts payable after more than one year 17 €46,915 €46,915 = 0.0%
Financial debts 170/4 €46,915 €46,915 = 0.0%
Amounts payable within one year 42/48 €730,267 €863,493 +€133,226 +18.2%
Trade debts 44 €31,041 €58,615 +€27,574 +88.8%
Suppliers 440/4 €31,041 €58,615 +€27,574 +88.8%
Taxes, remuneration and social security 45 €44,334 €34,884 -€9,450 -21.3%
Taxes 450/3 €8,243 €9,458 +€1,215 +14.7%
Remuneration and social security 454/9 €36,091 €25,426 -€10,665 -29.6%
Other amounts payable 47/48 €654,891 €769,994 +€115,102 +17.6%
Remuneration, social security and pensions 62 €122,364 €103,070 -€19,294 -15.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €8,949 €14,011 +€5,062 +56.6%
Other operating charges 640/8 €651 €1,492 +€842 +129.4%
Gross operating margin 9900 -€89,823 -€38,922 +€50,901 +56.7%
Operating profit (loss) 9901 -€221,786 -€157,495 +€64,291 +29.0%
Financial income 75/76B €75 €14 -€61 -81.1%
Recurring financial income 75 €75 €14 -€61 -81.1%
Financial charges 65/66B €945 €187 -€757 -80.2%
Recurring financial charges 65 €945 €187 -€757 -80.2%
Profit (loss) for the period before taxes 9903 -€222,656 -€157,668 +€64,988 +29.2%
Income taxes 67/77 €144 €176 +€32 +22.4%
Profit (loss) for the period 9904 -€222,800 -€157,844 +€64,955 +29.2%
Profit (loss) for the period to be appropriated 9905 -€222,800 -€157,844 +€64,955 +29.2%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.